{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:12:50Z","timestamp":1762917170690},"reference-count":36,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1987,11,1]]},"DOI":"10.1136\/jnnp.50.11.1522","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:16:40Z","timestamp":1226351800000},"page":"1522-1525","source":"Crossref","is-referenced-by-count":13,"title":["Meige syndrome: double-blind crossover study of sodium valproate."],"prefix":"10.1136","volume":"50","author":[{"given":"J W","family":"Snoek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W","family":"van Weerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"Teelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"van den Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Lakke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.29.8.1126","article-title":"Meige disease: striatal dopaminergic preponderance","volume":"29","author":"Tolosa, E.S.; Lai, C.","year":"1979","unstructured":"Tolosa ES, Lai C. Meige disease: striatal dopaminergic preponderance. Neurology 1979;29:1126-30.","journal-title":"Neurology"},{"issue":"32","key":"ref_2","first-page":"889","article-title":"and neurotransmitter mechanisms in the dystonias","volume":"1982","author":"Stahl, S.M.; Bromocriptine, Berger P.A.; physostigmine","unstructured":"Stahl SM, Berger PA. Bromocriptine, physostigmine. and neurotransmitter mechanisms in the dystonias. Neurology 1982,32:889-92.","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00002826-198312000-00003","article-title":"Neuropharmacological profile of Meige's disease: overview and a case report","volume":"6","author":"Ortiz, A.","year":"1983","unstructured":"Ortiz A. Neuropharmacological profile of Meige's disease: overview and a case report. Clin Neuropharmac-ol 1983;6:297-304.","journal-title":"Clin Neuropharmac-ol"},{"key":"ref_4","first-page":"100","article-title":"Pharmacology of cranial dystonia","volume":"1","author":"Marsden, C.D.; Lang, A.E.; Sheehy, M.P.","year":"1983","unstructured":"Marsden CD, Lang AE, Sheehy MP. Pharmacology of cranial dystonia. Neurology 1983;33:1 100-1.","journal-title":"Neurology"},{"key":"ref_5","first-page":"359","article-title":"Cerebrospinal fluid GABA in neurological disease. Neurologs'","volume":"28","author":"Neophytides, A.; Suria, A.; Chase, T.N.","year":"1978","unstructured":"Neophytides A, Suria A, Chase TN. Cerebrospinal fluid GABA in neurological disease. Neurologs' 1978;28:359."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.410050418","article-title":"Blepharospasm: successful treatment with clonazepam","volume":"5","author":"Merikangas, JR, Reynolds; C.F.","year":"1979","unstructured":"Merikangas JR, Reynolds CF. Blepharospasm: successful treatment with clonazepam. Ann Neurol 1979;5:401-2.","journal-title":"Ann Neurol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bmj.285.6345.853","article-title":"Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia)","volume":"285","author":"Brennan, M.J.W.; Sandyk, Ruff P.; R.","year":"1982","unstructured":"Brennan MJW, Ruff P. Sandyk R. Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia). Br Med J 1982;285:853.","journal-title":"Br Med J"},{"key":"ref_8","first-page":"207","article-title":"Therapeutic trials in Meige syndrome","volume":"37","author":"Gollomp, S.M.; Fahn, S.; Burke, R.E.; Reches, A.; Ilson, J.","year":"1983","unstructured":"Gollomp SM, Fahn S, Burke RE, Reches A, Ilson J. Therapeutic trials in Meige syndrome. In: Fahn S, Caine DB, Shoulson 1. Experimental Therapeutics of Movement Disorders. Advances in Neurology, vol 37. New York: Raven Press, 1983:207-13.","journal-title":"Advances in Neurology; DB, Shoulson 1. Experimental Therapeutics of Movement Disorders"},{"issue":"23","key":"ref_9","first-page":"474","article-title":"Meige's syndrome: acute and chronic responses to clonazepam and anticholinergics","volume":"1984","author":"Hipola, D.; Mateo, D.; Gimenez-Roldan","unstructured":"Hipola D, Mateo D, Gimenez-Roldan. Meige's syndrome: acute and chronic responses to clonazepam and anticholinergics. Eur Neurol 1984:23:474-8.","journal-title":"Eur Neurol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(82)91522-7","article-title":"Neurotransmitters and CNS disease: epilepsy","volume":"2","author":"Spero, L.","year":"1982","unstructured":"Spero L. Neurotransmitters and CNS disease: epilepsy. Lancet 1982:2:1319-22.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0361-9230(80)90095-7","article-title":"Effect of sodium-valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in men","volume":"5","author":"Zimmer, R.; Giindirewa, Teelken A.W.; M, Rither E.Cramer; H.","year":"1980","unstructured":"Zimmer R, Teelken AW. Giindirewa M, Rither E. Cramer H. Effect of sodium-valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in men. Brain Res Bull 1980;5:585-8.","journal-title":"Brain Res Bull"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archneur.1979.00500460069010","article-title":"Meige's disease. A clinical form of facial convulsion, bilateral","volume":"36","author":"Tolosa, E.S.; Klawans, H.L.","year":"1979","unstructured":"Tolosa ES, Klawans HL. Meige's disease. A clinical form of facial convulsion, bilateral and medial. Arch Neurol 1979;36:635-7.","journal-title":"and medial. Arch Neurol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/clinchem\/24.2.256","article-title":"Automated assay of gamma-amino-butyric acid in human cerebrospinal fluid","volume":"24","author":"B6hlen, P.; Schechter, P.J.; van Damme, W.; Coquillat, G.; Dosch, J.C.; Koch-Wesser, J.","year":"1978","unstructured":"B6hlen P, Schechter PJ, van Damme W, Coquillat G, Dosch JC, Koch-Wesser J. Automated assay of gamma-amino-butyric acid in human cerebrospinal fluid. Clin Chem 1978;24:256-60.","journal-title":"Clin Chem"},{"key":"ref_14","first-page":"142","article-title":"The adult onset focal dystonias, chap 11. In: Tics and Related Disorders","author":"Lees, A.J.","year":"1985","unstructured":"Lees AJ. The adult onset focal dystonias, chap 11. In: Tics and Related Disorders. London: Churchill Livingstone, 1985: 142-55."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/108.3.593","article-title":"Pathophysiology of blepharospasm and oromandibular dystonia","volume":"108","author":"Berardelli, A.; Rothwell, J.C.; Day, B.L.; Marsden, C.D.","year":"1985","unstructured":"Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985;108:593-608.","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.33.9.1237","article-title":"Blepharospasm associated with brainstem lesions","volume":"33","author":"Jankovic, J.; Patel, S.C.","year":"1983","unstructured":"Jankovic J, Patel SC. Blepharospasm associated with brainstem lesions. Neurologi 1983;33:1237-40.","journal-title":"Neurologi"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1212\/WNL.34.11.1522","article-title":"Blepharospasm associated with palatal myoclonus and communicating hydrocephalus","volume":"34","author":"Lange, A.E.; Sharpe, J.A.","year":"1984","unstructured":"Lange AE, Sharpe JA. Blepharospasm associated with palatal myoclonus and communicating hydrocephalus. Neurology 1984;34: 1522-3.","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/archneur.1985.04060110088025","article-title":"Blepharospasm with bilateral basal ganglia infarction","volume":"42","author":"Keane, JR, Young; J.A.","year":"1985","unstructured":"Keane JR, Young JA. Blepharospasm with bilateral basal ganglia infarction. Arch Neurol 1985;42:1206-8.","journal-title":"Arch Neurol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0303-8467(81)90016-0","article-title":"Meige's syndrome: clinical, pharmacological and radiological observations","volume":"83","author":"Chopra, J.S.; Radhakrishnan, K.; Sridharan, R.","year":"1981","unstructured":"Chopra JS, Radhakrishnan K, Sridharan R. Meige's syndrome: clinical, pharmacological and radiological observations. Clin Neurol Neurosurg 1981;83:145-52.","journal-title":"Clin Neurol Neurosurg"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0303-8467(85)90042-3","article-title":"Meige syndrome: review of 8 cases","volume":"87","author":"Snoek, J.W.; van Weerden, T.W.; Lakke, J.P.W.F.","year":"1985","unstructured":"Snoek JW, van Weerden TW, Lakke JPWF. Meige syndrome: review of 8 cases. Clin Neurol Neurosurg 1985;87:236-7.","journal-title":"Clin Neurol Neurosurg"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.30.7.690","article-title":"Pharmacology of blepharospasm-oromandibular dystonia syndrome","volume":"30","author":"Casey, D.E.","year":"1980","unstructured":"Casey DE. Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology 1980;30:690-5.","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/WNL.32.7.783","article-title":"Meige disease: acute and chronic cholinergic effects","volume":"32","author":"Tanner, C.M.; Glantz, R.H.; Klawans, H.L.","year":"1982","unstructured":"Tanner CM, Glantz RH, Klawans HL. Meige disease: acute and chronic cholinergic effects. Neurology 1982;32:783-5.","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients","volume":"13","author":"Jankovic, J.; Ford, J.","year":"1983","unstructured":"Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983;13:402-1 1.","journal-title":"Ann Neurol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.32.4.432","article-title":"Beneficial effects of lisuride in Meige disease","volume":"32","author":"Micheli, F.; Fernandez Pardal, M.M.; Leiguarda, R.C.","year":"1982","unstructured":"Micheli F, Fernandez Pardal MM, Leiguarda RC. Beneficial effects of lisuride in Meige disease. Neurology 1982;32:432-4.","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1212\/WNL.35.5.766","article-title":"Lisuride in dystonia","volume":"35","author":"AE, Quinn N.P.Lang; MP, Sheehy; CD, Marsden","year":"1985","unstructured":"Quinn NP. Lang AE, Sheehy MP, Marsden CD. Lisuride in dystonia. Neurology 1985;35:766-9.","journal-title":"Neurology"},{"key":"ref_26","first-page":"106","article-title":"Treatment of blepharospasm with high-dose baclofen","volume":"14","author":"Fahn, S.; Bressman, S.; Burke, R.; Hening, W.; Ilson, J.; Walters, A.","year":"1983","unstructured":"Fahn S, Bressman S, Burke R, Hening W, Ilson J, Walters A. Treatment of blepharospasm with high-dose baclofen. Ann Neurol 1983;14:106.","journal-title":"Ann Neurol"},{"key":"ref_27","first-page":"957","article-title":"Choline for blepharospasm","volume":"2","author":"Skarf, J.B.; Sharpe, J.A.","year":"1981","unstructured":"Skarf JB, Sharpe JA. Choline for blepharospasm. Lancet 1981;2:957-8.","journal-title":"Lancet"},{"issue":"1","key":"ref_28","first-page":"147","article-title":"Treatment of Meige syndrome with cannabidiol","volume":"34","author":"Snider, SR, Consroe; P.","year":"1984","unstructured":"Snider SR, Consroe P. Treatment of Meige syndrome with cannabidiol. Neurology 1984;34(suppl 1):147.","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00002826-198205030-00004","article-title":"Pharmacology of GABA","volume":"5","author":"Meldrum, B.","year":"1982","unstructured":"Meldrum B. Pharmacology of GABA. Clin Neuropharmacol 1982;5:293-3 16.","journal-title":"Clin Neuropharmacol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1600-0404.1985.tb00881.x","article-title":"Progabide in the treatment of hyperkinetic extrapyramidal movement disorders","volume":"72","author":"Mondrup, K.; Dupont, E.; Braendgaard, H.","year":"1985","unstructured":"Mondrup K, Dupont E, Braendgaard H. Progabide in the treatment of hyperkinetic extrapyramidal movement disorders. Acta Neurol Scand 1985;72:341-3.","journal-title":"Acta Neurol Scand"},{"key":"ref_31","first-page":"1","article-title":"Gamma-vinyl GABA in tardive dyskinesia and other movement disorders","volume":"34","author":"Stahl, S.M.; Thornton, J.E.; Simpson, M.L.; Berger, P.A.","year":"1984","unstructured":"Stahl SM, Thornton JE, Simpson ML, Berger PA. Gamma-vinyl GABA in tardive dyskinesia and other movement disorders. Neurologi 1984;34(suppl 1):85-6.","journal-title":"Neurologi"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","article-title":"Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome)","volume":"39","author":"Marsden, C.D.","year":"1976","unstructured":"Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). J Neurol Neurosurg PsYchiatrY 1976;39:1204-9.","journal-title":"J Neurol Neurosurg PsYchiatrY"},{"key":"ref_33","first-page":"483","article-title":"Sodium valproate in tardive dyskinesia","volume":"40","author":"Casey, D.E.; Hammerstad, J.P.","year":"1979","unstructured":"Casey DE, Hammerstad JP. Sodium valproate in tardive dyskinesia. J Clin Psvchiatrv 1979;40:483-5.","journal-title":"J Clin Psvchiatrv"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.31.12.1555","article-title":"Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy","volume":"31","author":"Weiner, W.J.; Nausieda, P.A.; Glantz, R.H.","year":"1981","unstructured":"Weiner WJ, Nausieda PA, Glantz RH. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology 1981;31:1555-6.","journal-title":"Neurology"},{"key":"ref_35","first-page":"445","article-title":"Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia","volume":"43","author":"Stahl, S.M.; Yesavage, J.A.; Berger, P.A.","year":"1982","unstructured":"Stahl SM, Yesavage JA, Berger PA. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia. J Clin Pssychiatry 1982;43:445-6.","journal-title":"J Clin Pssychiatry"},{"key":"ref_36","first-page":"79","article-title":"GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease","volume":"45","author":"Bartholini, G.; Scatton, B.; Lloyd, Zivkovic B.; K.G.","year":"1987","unstructured":"Bartholini G, Scatton B, Zivkovic B. Lloyd KG. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. In: Yahr MD, Bergmann KJ. Parkinson's disease. Advances in Neurology, vol. 45. New York: Raven Press, 1987:79-83.","journal-title":"KJ. Parkinson's disease. Advances in Neurology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.50.11.1522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:16:15Z","timestamp":1601093775000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.50.11.1522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1987,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.50.11.1522","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1987,11,1]]}}}